Group items tagged

"JERSEY CITY, NJ--(SharewellNewsWire.com-07/05/12)- Aoxing Pharmaceutical Company, Inc. (NYSEAMEX:AXN), a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotics and pain-management products, today announced that Mr. Bob Yunjun Ai has resigned as Chief Financial Officer of the Company to pursue other business interests, effective as of July 1, 2012. The Company expresses its appreciation for Mr. Ai's significant contributions to the Company and wishes him the best in his future endeavors. "

"Bristol-Myers Squibb Co has agreed to acquire Amylin Pharmaceuticals Inc, a maker of diabetes therapies at a total cost of $5.3 billion as it is desperately trying to replace revenue that it is losing from the declining sales of its blood thinner that is facing generic competition."

"In the largest settlement involving a pharmaceutical company, the British drug maker, GlaxoSmithKline has agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best selling antidepressants for unapproved uses and for failing to report safety data about a top diabetes drug. "